No hasty solutions for African swine fever

sappo-vaccinenog

The race to develop an ASFV vaccine may overshadow comprehensive efficacy and safety testing, thus potentially investing in the wrong vaccine development strategy and in unnecessary use of animals for experiments.

Additional caution should be taken when developing LAV vaccines to be spread in nature in oral baits. The challenge of ASFV vaccine development, including vaccination of wild boar, should not be underestimated and requires the cooperation of many disciplines in the early stages of vaccine development.
Read more

Share on facebook
Share on twitter
Share on linkedin